drugset / Trial / NCT03954015

Comparison of Three Methods for Early Detection of Breast Cancer

NCT03954015

Phase 0 Completed 3 enrolled Mayo Clinic
NaSingle-groupOpen-labelDiagnostic

Summary

Subjects with suspicious breast lesion (BIRADS category 4/5) who are scheduled to undergo biopsy will be recruited to undergo imaging evaluation with Contrast Enhanced Dual Energy Mammography (CEDM), Contrast Enhanced Breast MR (CEMR) and Contrast Enhanced Ultrasound (CEUS).

Timeline

Start
2019-10-15
Primary completion
2020-06-30
Completion
2021-10-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lumason Diagnostic / imaging agent